Chromogranin A pathway: from pathogenic molecule to renal disease
Saiful A. Mir(University of California San Diego), Sucheta M. Vaingankar(Uppsala University), Ji Wan(Apple (Israel)), Daniel T. O’Connor(Nova Southeastern University), Wai Cheung(Apple (Israel)), Nicholas J. G. Webster(University of California San Diego), Nilima Biswas(University of California San Diego), Etienne Macedo(University of California San Diego Medical Center)
Cited by 5
Related Papers
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
The Chromogranin–Secretogranin Family
|New England Journal of Medicine|2003|820
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
|JAMA Network Open|2020|644
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
|New England Journal of Medicine|1986|484